CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.57
0.13 (2.93%)
▲
5d:
-9.68%
30d:
-6.54%
90d:
+136.79%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Smart Money Accumulation
None View Scanner →
Strength: 9.0/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
16 traders called CLOV this week
76% bullish • 5 bearish
76% bullish • 5 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLOV trades at premium valuation expecting 8.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CLOV trades at premium valuation expecting 8.6% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.57, which is considered slightly low relative to its 30-day fair value range of $4.40 to $5.27. From a valuation perspective, the stock is trading at a premium (Forward PE: 45.7) compared to its historical average (35.7). At these levels, the market is pricing in 8.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLOV is in a strong uptrend. The price is currently testing key support at $4.72. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLOV is in a strong uptrend. The price is currently testing key support at $4.72. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.40 -
$5.27
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.4%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($4.15)
- NEUTRAL: Trading at premium valuation - market expects 8.6% growth which is achievable
- CAUTION: Recommendation downgraded due to -9.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$4.40 -
$5.27
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.72
Resistance Level
$5.59
Current Trend
Strong Uptrend
Technical data as of
Jul 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
45.70
Wall Street Target
$4.15
(-9.2%)
Revenue Growth (YoY)
62.0%
Profit Margin
-2.6%
Valuation Premium vs History
+8.6% premium
PE vs Historical
45.7 vs 35.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.6%
(market-implied from PE analysis)
1-Year Target
$4.96
(+9%)
2-Year Target
$5.39
(+18%)
3-Year Target
$5.85
(+28%)
3-Yr Target (if PE normalizes)
(PE: 46→36)
PE COMPRESSION
$4.57
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 45.7, Growth: 11.1%)
$6.27
(+37%)
Base:
(SPY PE: 21.8, Growth: 11.1%)
$2.99
(-35%)
Bear:
(PE: 18.5, Growth: 11.1%)
$2.54
(-44%)
Share & Embed Analysis
Last updated: July 14, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$109 | 65 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$420 | 54 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 62 BUY |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$431 | 64 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$315 | 58 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
